Cite
APA Citation
Alkharabsheh, O., Al‐Kali, A., Saadeh, S., He, R., Viswanatha, D., Greipp, P., Reichard, K., Shah, M., Gangat, N., Patnaik, M., Hogan, W., Litzow, M., Alkhateeb, H., & Nguyen, P. L. (n.d.). the clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS. American journal of hematology, 93(11), E355–E357. http://access.bl.uk/ark:/81055/vdc_100070818275.0x00003d